The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with Newcastle Premier Health Ltd

29 May 2020 07:00

RNS Number : 2923O
Catenae Innovation PLC
29 May 2020
 

29 May 2020

 

Catenae Innovation PLC

("Catenae", or the "Company")

 

Agreement with Newcastle Premier Health Ltd

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that it has signed an agreement with Newcastle Premier Health Limited ("NPH"), an occupational health and wellness business based in the North East of England.

 

Under the terms of the agreement, NPH will provide its knowhow to the Cov-ID project, a GDPR compliant identity documentation exchange system to record an individual's Covid-19 test status through a mobile app that is intended to be marketed to businesses and organisations.

 

As previously announced, the Cov-ID project is a joint initiative by a consortium of companies led by the Z/Yen Group.

 

NPH has agreed to pilot the Cov-ID app which is expected to commence on 29 May 2020.

 

 

Guy Meyer, Interim Chief Executive Officer of Catenae, commented: "We are delighted that occupational health and wellness business, Newcastle Premier Health, will pilot the Company's Cov-ID mobile app technology on a selection of its employees in its efforts to return to work safely. Upon publication of a proof of concept, which is expected to take place within the next few weeks, the app will be available to be rolled out to benefit businesses and organisations as current restrictions begin to ease. We look forward to updating the market in due course."

 

Mark Philpott, Managing Director of NPH, said: "As a responsible and ethical occupational health provider, we understand the importance of enabling our clients and other local businesses to return to work safely and at an appropriate time in line with the best scientific and government advice available. We are looking forward to combining our clinical and occupational health expertise within the Cov-ID project, with the expertise of the other consortium members."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Interim Chief Executive Officer of the Company.

- Ends -

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0) 191 580 8545

Guy Meyer, Interim Chief Executive Officer

 

 

 

 

 

Cairn Financial Advisers LLP (Nominated Adviser)

+44 (0)20 7213 0880

Liam Murray

Jo Turner

 

 

 

 

 

 

Brandon Hill Capital Limited Broker

Andy Gutmann

+44 (0) 20 3463 5000

+44 (0)78796 8313

 

 

 

Yellow Jersey PR (PR & IR)

+44 (0)20 3004 9512

Sarah Hollins

Annabel Atkins

 

 

Notes to Editors:

 

About Catenae Innovation PLC

Catenae Innovation is an AIM quoted provider of digital media and technology services. The Company specialises in Distributed Ledger Technology solutions that solve commercial challenges and create opportunities for its clients. The Company has an experienced IT team of project managers and integrators who have deployed systems across corporate, government and educational sectors.

 

www.catenaeinnovation.com

 

About NPH Group

The NPH Group are a leading healthcare provider based in the North East of England. NPH offer Covid-19 strategic consultancy to global clients and UK testing services nationally. In addition to a full range of professional Occupational Health and Wellbeing services, they help businesses and organisations achieve their strategic personnel goals, ensuring business remain compliant and productive.

 

www.newcastlepremierhealth.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRUWURRRRUVUUR
Date   Source Headline
1st Jul 20203:12 pmRNSTotal Voting Rights
1st Jul 20202:06 pmRNSSecond Price Monitoring Extn
1st Jul 20202:00 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSCompletion of Cov-ID Project
30th Jun 20207:01 amRNSHalf-year Report
30th Jun 20207:00 amRNSFinal Results
26th Jun 20204:30 pmRNSExercise of Warrant
23rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20204:36 pmRNSPrice Monitoring Extension
19th Jun 20207:00 amRNSCov-ID Project Update
12th Jun 20209:58 amRNSIssue of Equity
11th Jun 20202:02 pmRNSShare Price Movement and Update
10th Jun 202012:30 pmRNSExercise of Warrant, Conversion & Issue of Equity
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
29th May 202012:24 pmRNSHolding(s) in Company
29th May 20207:00 amRNSAgreement with Newcastle Premier Health Ltd
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
21st May 20207:00 amRNSExercise of Warrant and Issue of Equity
18th May 20207:00 amRNSCov-ID Project Update
14th May 202012:49 pmRNSResult of General Meeting and Issue of Equity
1st May 20209:00 amRNSUpdate - Cov-ID Project
29th Apr 20205:09 pmRNSPosting of Circular and Notice of General Meeting
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSDirectorate Changes
23rd Apr 202012:19 pmRNSHolding(s) in Company
21st Apr 20202:05 pmRNSSecond Price Monitoring Extn
21st Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 20203:32 pmRNSConditional Placing to raise £320,000 and Update
17th Apr 20207:00 amRNSCatenae joins Consortium on Cov-ID Project
16th Apr 20205:30 pmRNSChange of Broker
31st Mar 20202:45 pmRNSHolding(s) in Company
31st Mar 20202:40 pmRNSHolding(s) in Company
31st Mar 20202:35 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNSAnnual Report, Trading & COVID-19 Update
26th Mar 202012:49 pmRNSWorking Capital Facility
31st Jan 20201:36 pmRNSIssue of Equity & Proposed Directorate Change
24th Jan 20201:20 pmRNSUpdate re Working Capital & Balance Sheet
10th Jan 202012:23 pmRNSUpdate re Working Capital & Balance Sheet
23rd Dec 201911:37 amRNSResult of General Meeting
20th Dec 20195:02 pmRNSUpdate re Working Capital
20th Dec 20191:23 pmRNSFurther re Share Capital & Timetable Update
20th Dec 20197:00 amRNSShare Capital and Total Voting Rights
19th Dec 20197:00 amRNSFurther re Agreements and update
6th Dec 201910:53 amRNSPosting of Circular and Notice of General Meeting
12th Sep 201910:50 amRNSHolding(s) in Company
11th Sep 20197:30 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.